A woman multi-tasks while holding a mug in Teva's latest ad for TD drug Austedo. (Credit: Teva)
February 5, 2024 02:56 PM ESTUpdated 03:40 PM
Pharma
Marketing

New Te­va ad cam­paign fo­cus­es on pa­tients strug­gling with psy­chi­atric drug side ef­fect

Nicole DeFeudis

Editor

Te­va is fo­cused on grow­ing its Auste­do brand to treat tar­dive dysk­i­ne­sia, a side ef­fect of some men­tal health med­ica­tions, jump­start­ing this year with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

A service from the Financial Times